Statistics Collaborative - Design and analysis for biomedical research

PublicationsPublications

Janet Wittes

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8

  • Sonis S, Eilers J, Epstein J, LeVeque F, Liggett W, Mulagha M, Peterson D, Rose A, Schubert M, Spijkervet F, Wittes J. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999; 85:2103-2113.
  • Rubins H, Robins S, Collins D, Fye C, Anderson J, Elam M, Faas F, Linares E, Schaefer E, Schectman G, Wilt T, Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341:410-418.
  • Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.  The Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709-717.
  • Nichol K, Mendelman P, Mallon K, Jackson L, Gorse G, Belshe R, Glezen W, Wittes J. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-144.
  • Iwane M, Wittes J, Collins D, Rubins H. Simultaneous screening for three correlated lipids in the VA HDL Intervention Trial. J Clin Epidemiol 1999; 52:685-693.
  • Derkx B, Wittes J, McCloskey R. Randomized, placebo-controlled trial of HA-1A, a human monoclonal anti-endotoxin antibody, in children with meningococcal septic shock. Clin Infect Dis 1999; 28:770-777.
  • Wittes J, Friedman H. Editorial: Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data. JNCI 1999; 91:400-401.
  • Wittes J. Disentangling competing risks in clinical trials. Actes du Seminaire. Vannes: 3, 5-22, 1998-1999.
  • The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59.
  • Judd J, Baer D, Clevidence B, Muesing R, Chen S, Weststrate J, Meijer G, Wittes J, Lichtenstein A, Vilella-Bach M, Schaefer E. Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets. Am J Clin Nutr 1998; 68:768-777.
  • Black H, Elliott W, Neaton J, Grandits G, Grambsch P, Grimm R, Hansson L, Lacouciere Y, Muller J, Sleight P, Weber M, White W, Williams G, Wittes J, Zanchetti A, Fakouhi T. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials 1998; 19:370-390.
  • Belshe R, Mendelman P, Treanor J, King J, Gruber W, Piedra P, Bernstein D, Hayden F, Kotloff K, Zangwill K, Iacuzio D, Wolff M, Reisinger K, Block S, Wittes J, Rabinovich R. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338:1405-1412.
  • The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997; 99:93-99.
  • The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997; 336:153-162.
  • Clevidence B, Judd J, Schaefer E, Jenner J, Lichtenstein A, Muesing R, Wittes J, Sunkin M. Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids. Arterioscler Thromb Vasc Biol 1997; 17:1657-1661.
  • Brittain E, Palensky J, Blood J, Wittes J. Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP). Stat Med 1997; 16:681-693.
  • Wittes J, Kelly A, Plante K. Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients. Transplant Proc 1996; 28:17-24.
  • Wittes J. A statistical perspective on adverse event reporting in clinical trials. Biopharm Rep 1996; 4:5-10.
  • The ALS CNTF treatment study (ACTS) phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996; 53:141-147.
  • Sherwood J, Copeland R, Taylor K, Abok K, Oloo A, Were J, Strickland G, Gordon D, Ballou W, Bales J, Wirtz R, Wittes J, Gross M, Que J, Cryz S, Oster C, Roberts C, Sadoff J. Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Vaccine 1996; 14:817-827.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8